CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOISVERT, M.
Right arrow Articles by HUDON, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BOISVERT, M.
Right arrow Articles by HUDON, F.

Canadian Journal of Anesthesia, Vol 9, 325-330, Copyright © 1962 by Canadian Anesthesiologists' Society

Clinical Evaluation of Methoxyflurane in Obstetrical Anaesthesia: A Report on 500 Cases

MICHEL BOISVERT M.D., B.PH.1 and FERNANDO HUDON M.D., F.R.C.P.(C)1

1 Department of Anaesthesia, Hôtel-Dieu de Québec, Quebec

Methoxyflurane has been used for general anaesthesia in 500 unselected consecutive cases of vaginal deliveries. The outstanding features of the drug are the rapidity of induction, high level of analgesia under a light plane of anaesthesia, very low incidence of vomiting, minimal depression of uterine contractions, minimal respiratory depression of the foetus, quiet and rapid recovery.

In our opinion, it is the drug of choice in obstetrical anaesthesia. We are at the moment experimenting with the use of Penthrane in Caesarean sections and present data show it to be a promising agent.

Note:

Doctor Boisvert is now First Assistant in the Department of Anaesthesia of the Hospital St-Ambroise de Loretteville.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1962 by the Canadian Anesthesiologists' Society.